With the analysis among 113 patents, we discovered top 19 key players by total patent application. Cornell Research Foundation, Inc., MedImmune Ltd., ADC Therapeutics SA are dominant in this area. They take 47.79% of the total patent filing.
Cornell Research Foundation, Inc.
New York, United States
Patent: 19
Cambridgeshire, United Kingdom
Patent: 18
Vaud, Switzerland
Patent: 17
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 9
California, United States
Patent: 9
Sorrento Therapeutics, Inc.
California, United States
Patent: 7
Delaware, United States
Patent: 6
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
No data, please try another search term
With the analysis among related 9 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing MedImmune Ltd., Regeneron Pharmaceuticals, Inc., ADC Therapeutics SA take 66.67% of patent filing during this period.
Cambridgeshire, United Kingdom
Patent: 2
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 2
Vaud, Switzerland
Patent: 2
California, United States
Patent: 2
Sorrento Therapeutics, Inc.
California, United States
Patent: 1
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 1
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 9 patents in last 5 years, we discover 2 new entrants.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 1
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
No data, please try another search term